In contrast, high-grade serous ovarian carcinomas (HG-SOC) and undifferentiated carcinomas—which are characterized by p53 and BRCA1/2 mutations and genomic instability—present at an advanced stage, evolve aggressively, and have poor prognosis. The gene discussed is TP53; the disease is ovarian serous carcinoma.